OOIR: Observatory of International Research

Papers

(The H4-Index of Chest is 57. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Antithrombotic Therapy for VTE Disease	479
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019	355
Executive Summary	256
Hospital-Acquired Infections in Critically Ill Patients With COVID-19	245
Persistent Exertional Intolerance After COVID-19	218
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19	175
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma	171
Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension	164
Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza	147
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019	146
Robotic Bronchoscopy for Peripheral Pulmonary Lesions	142
Eosinophilic and Noneosinophilic Asthma	140
Perioperative Management of Antithrombotic Therapy	137
Screening for Lung Cancer	137
Disparities in Sleep Health and Potential Intervention Models	134
Diagnosis and Evaluation of Hypersensitivity Pneumonitis	129
High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure	128
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes	128
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU	127
Medical Education During the COVID-19 Pandemic	125
The Coronavirus Disease 2019 Pandemic’s Effect on Critical Care Resources and Health-Care Providers	116
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults	115
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis	109
Pulmonary Thrombosis and Thromboembolism in COVID-19	102
Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions	96

Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism	96
Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality	95
Chest CT Imaging Signature of Coronavirus Disease 2019 Infection	90
Treatment of Mycobacterium abscessus Pulmonary Disease	88
Chest CT in COVID-19 at the ED: Validation of the COVID-19 Reporting and Data System (CO-RADS) and CT Severity Score	80
Right Ventricular Dysfunction in Early Sepsis and Septic Shock	80
VTE in ICU Patients With COVID-19	75
Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019	73
Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units	73
Feasibility of a 5G-Based Robot-Assisted Remote Ultrasound System for Cardiopulmonary Assessment of Patients With Coronavirus Disease 2019	73
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer	71
Relationship Between CPAP Termination and All-Cause Mortality	70
Projecting Long-term Health and Economic Burden of COPD in the United States	69
Acetazolamide for OSA and Central Sleep Apnea	69
Risk Factors for Invasive Candida Infection in Critically Ill Patients	67
Pulmonary Hypertension in Patients With COPD	66
Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases	66
Symptoms of Mental Health Disorders in Critical Care Physicians Facing the Second COVID-19 Wave	66
Addressing Race in Pulmonary Function Testing by Aligning Intent and Evidence With Practice and Perception	65
Racial Bias in Pulse Oximetry Measurement Among Patients About to Undergo Extracorporeal Membrane Oxygenation in 2019-2020	64
Lung Cancer Screening Rates During the COVID-19 Pandemic	64
Age and Sex Disparities in Adherence to CPAP	64
Thromboprophylaxis in Patients With COVID-19	62
The Minimal Effect of Zinc on the Survival of Hospitalized Patients With COVID-19	61
Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation	60
Tobacco Smoking and Risk for Pulmonary Fibrosis	60
Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic	60
Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic	59
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm	59
Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors	58
Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	57
The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19	57